Advertisement
Canada markets open in 2 hours 27 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7324
    +0.0001 (+0.02%)
     

  • CRUDE OIL

    84.10
    +0.53 (+0.63%)
     

  • Bitcoin CAD

    87,570.08
    +810.80 (+0.93%)
     

  • CMC Crypto 200

    1,386.39
    -10.15 (-0.73%)
     

  • GOLD FUTURES

    2,360.10
    +17.60 (+0.75%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,735.75
    +168.25 (+0.96%)
     

  • VOLATILITY

    15.64
    +0.27 (+1.76%)
     

  • FTSE

    8,116.02
    +37.16 (+0.46%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6823
    +0.0002 (+0.03%)
     

Five Star Equities Issues New Research Reports on ANGO, CHTP, FRAN and YRCW

ACCESSWIRE

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

AngioDynamics, Inc. (NASDAQ:ANGO - News) shares increased 2.67 percent to close at $18.46 a share Friday. The stock traded between $16.81 and $19.00 on volume 776,612 shares traded. The company reported net sales were $88.6 million for the second quarter of fiscal 2014, an increase of 2.0 percent when compared to a year ago. Shares of AngioDynamics have gained approximately 60.0 percent in the past year.

Get more information on AngioDynamics and free access to the in-depth equity report at:
www.FiveStarEquities.com/ANGO

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP - News) shares dropped 29.18 percent to close at $2.48 a share Friday. The stock traded between $2.26 and $2.72 on volume 18.93 million shares traded. Materials posted to the FDA have raised speculation that Northera would not receive approval. Shares of Chelsea Therapeutics have gained approximately 180.0 percent in the past year.

ADVERTISEMENT

Get more information on Chelsea Therapeutics and free access to the in-depth equity report at:
www.FiveStarEquities.com/CHTP

Francesca's Holdings Corp. (NASDAQ:FRAN - News) shares surged 24.45 percent to close at $22.50 a share Friday. The stock traded between $19.65 and $22.60 on volume of 6.70 million shares traded. The company now expects revenues for the fourth quarter of 2013 to be in the range of $93.0 million to $95.0 million, up from its previous guidance of $90.0 million to $95.0 million. Shares of Francesca's Holdings have fallen approximately 20.0 percent in the past year.

Get more information on Francesca's Holdings and free access to the in-depth equity report at:
www.FiveStarEquities.com/FRAN

YRC Worldwide, Inc. (NASDAQ:YRCW - News) shares fell 13.34 percent to close at $13.58 a share Friday. The stock traded between $11.81 and $13.75 on volume 6.57 million shares traded. The company announced that The International Brotherhood of Teamsters did not approve its contract extension proposal. Shares of YRC Worldwide have gained approximately 100.0 percent in the past year.

Get more information on YRC Worldwide free access to the in-depth equity report at:
www.FiveStarEquities.com/YRCW

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com